Efficacy and safety of Levamisole treatment in clinical presentations of non-hospitalized patients with COVID-19: a double-blind, randomized, controlled trial

BACKGROUND: Levamisole has shown clinical benefits in the management of COVID-19 via its immunomodulatory effect. However, the exact role of Levamisole effect in clinical status of COVID-19 patients is unknown. We aimed to evaluate the efficacy of Levamisole on clinical status of patients with COVID...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Infect Dis
Hlavní autoři: Roostaei Firozabad, Amirreza, Meybodi, Zohreh Akhoundi, Mousavinasab, Seyed Ruhollah, Sahebnasagh, Adeleh, Jelodar, Mohsen Gholinataj, Karimzadeh, Iman, Habtemariam, Solomon, Saghafi, Fatemeh
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2021
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7988635/
https://ncbi.nlm.nih.gov/pubmed/33761870
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-021-05983-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky